Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
CLINICAL CANCER RESEARCH
Journal
Overview
Research
Identifiers
Other
View All
Overview
publication venue for
DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
. 28:1948-1965.
2022
Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy
. 27:1019-1028.
2021
A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma
. 25:5799-5807.
2019
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells
. 24:4874-4886.
2018
Exosome-Based Detection of
EGFR
T790M in Plasma from Non-Small Cell Lung Cancer Patients
. 24:2944-2950.
2018
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
. 23:562-574.
2017
Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
. 22:3937-3949.
2016
The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
. 22:2217-2225.
2016
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
. 21:3969-3976.
2015
FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3-FOXO1 Fusion Gene
. 20:3884-3895.
2014
Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models
In Vitro
and
In Vivo
. 18:5911-5923.
2012
Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
. 17:4872-4881.
2011
Gene expression profiles of luteal phase fallopian tube epithelium from
BRCA
mutation carriers resemble high-grade serous carcinoma
. 14:4067-4078.
2008
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma
. 13:7401-7406.
2007
Relaxin promotes prostate cancer progression
. 13:1695-1702.
2007
Targeted therapy for brain metastases: Improving the therapeutic ratio
. 13:1675-1683.
2007
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08
. 12:4899-4907.
2006
Temozolomide-mediated radiation enhancement in glioblastoma: A report on underlying mechanisms
. 12:4738-4746.
2006
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei
. 12:206-213.
2006
c-Met ectodomain shedding rate correlates with malignant potential.
. 12:4154-4162.
2006
Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia
. 11:4460-4468.
2005
Inhibition of Src tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells
. 10:2307-2318.
2004
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman
. 8:549-554.
2002
Induction of transforming growth factor beta-1 in cervical intraepithelial neoplasia in vivo after treatment with beta-carotene
. 3:157-160.
1997
Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry
. 2:1981-1992.
1996
Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer
. 2:181-185.
1996
THE ROLE OF COLONY-STIMULATING FACTOR-1 AND ITS RECEPTOR IN THE ETIOPATHOGENESIS OF ENDOMETRIAL ADENOCARCINOMA
. 1:313-325.
1995
BRCA mutation status is not associated with better long-term survival from epithelial ovarian cancer.
2016
Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy.
2016
Combined Src and MEK inhibition decreases ovarian cancer (OVCA) cell growth, tumorigenicity and aldehyde dehydrogenase positive tumor-initiating-cells
2015
Preclinical efficacy of combined MEK and Src inhibition: MEK inhibitor reverses resistance to Src inhibitor therapy in ovarian cancer cells
2013
Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics
1999
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
2022
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
2022
Comprehensive genomic profiling identifies frequent drug-sensitive EGFR exon 19 deletions in NSCLC not identified by prior molecular testing
2016
Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
1999
Research
category
ONCOLOGY
Category
Identifiers
International Standard Serial Number (ISSN)
1078-0432
Electronic International Standard Serial Number (EISSN)
1557-3265
Other
journal abbreviation
CLIN CANCER RES